Reports
Global Point-of-Care (POC) Diagnostic Market Size, Forecast: By Product: Glucose Monitoring Kits, Infectious Diseases Testing Kits, Pregnancy and Fertility Testing Kits, Haematology Testing Kits, Cardiometabolic Monitoring Kits, Others; By Platform; By Mode of Purchase; By End Use; Regional Analysis; Competitive Landscape; 2024-2032
Global Point-of-Care (POC) Diagnostic Market Outlook
The global point-of-care (POC) diagnostic market is expected to grow at a CAGR of 8% in the forecast period of 2024-2032.
-diagnostic-market.png)
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
North America and Europe to Dominate the Global Point-of-Care (POC) Demand
North America and Europe are among the leading regions for the market for point-of care-diagnostics and are expected to be among the leading markets in the forecast period as well. The United States holds the major market share within the North American region. Factors such as the rising geriatric population as well as the rising prevalence of acute and chronic diseases are boosting the market growth. Moreover, various regulations and initiatives undertaken by the government in the region for the development of healthcare infrastructure are expected to boost the market growth.
Global Point-of-Care Diagnostic: Definition and Segmentation
Point-of-care (POC) diagnostics are the medical devices used to get immediate results in the investigation of various diseases including cancer, diabetes, and cardiac diseases. The diagnostic results obtained are on par with the lab quality while the time consumed is quite short. These point-of-care diagnostic are used in healthcare facilities as well as at home.
-diagnostic-market-by-end-use.png)
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Based on the product, the market can be classified into:
- Glucose Monitoring Kits
- Infectious Diseases Testing Kits
- Pregnancy and Fertility Testing Kits
- Haematology Testing Kits
- Cardiometabolic Monitoring Kits
- Urinalysis Testing Devices
- Coagulation Monitoring Kits
- Tumour or Cancer Markers Testing Devices
- Cholesterol Testing Strips
- Drugs of Abuse Testing Kits
- Faecal Occult Testing Kits
- Others
Based on the platform, the market can be segmented into:
- Lateral Flow Assays
- Dipsticks
- Microfluidics
- Molecular Diagnostics
- Immunoassays
- Others
Based on mode of purchase, the industry can be categorised as follows:
- Prescription-Based Products
- OTC Products
Based on the end use, market can be segmented into:
- Professional Diagnostic Centres
- Hospitals/Critical Care Centres
- Assisted Living Healthcare Facilities
- Research Laboratories
The regional markets for the product include North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
-diagnostic-market-by-region.png)
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Rising Cases of Acute and Chronic Diseases is Driving up the Market Demand
The demand for quality point-of-care (POC) testing kits is rapidly increasing because of rapidly increasing acute and chronic diseases. The large number of patients give rise to a need of shorter patient turnover time for more efficient medical services. The global point-of-care (POC) diagnostic industry is tapping into this demand with its quick and proper diagnostics and increasing its market value. The technological developments in diagnostic kits have resulted in fewer manual errors and emerged as a prominent driving factor for the market. Other factors include the rising population, increased disposable incomes, and the rapid growth of the healthcare industry.
Key Industry Players in the Global Point-of-Care (POC) Diagnostics Market
The report presents a detailed analysis of the following key players in the global point-of-care (POC) diagnostic market looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
- Abbott Point of Care Inc.
- F. Hoffmann-La Roche Ltd
- Chembio Diagnostics, Inc.
- Johnson & Johnson Services, Inc.
- Siemens AG
- Becton, Dickinson and Company
- Danaher Corp
- Others
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2023 |
| Historical Period | 2018-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report | Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Product, Platform, Mode of Purchase, End Use, Region |
| Breakup by Product | Glucose Monitoring Kits, Infectious Diseases Testing Kits, Pregnancy and Fertility Testing Kits, Haematology Testing Kits, Cardiometabolic Monitoring Kits, Urinalysis Testing Devices, Coagulation Monitoring Kits, Tumour or Cancer Markers Testing Devices, Cholesterol Testing Strips, Drugs of Abuse Testing Kits, Faecal Occult Testing Kits, Others |
| Breakup by Platform | Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics, Immunoassays, Others |
| Breakup by Mode of Purchase | Prescription-Based Products, OTC Products |
| Breakup by End Use | Professional Diagnostic Centres, Hospitals/Critical Care Centres, Assisted Living Healthcare Facilities, Research Laboratories |
| Breakup by Region | North America, Latin America, Europe, Middle East and Africa, Asia Pacific |
| Market Dynamics | SWOT, Porter's Five Forces, Key Indicators for Price and Demand |
| Competitive Landscape | Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications |
| Companies Covered | Abbott Point of Care Inc., F. Hoffmann-La Roche Ltd, Chembio Diagnostics, Inc., Johnson & Johnson Services, Inc., Siemens AG, Becton, Dickinson and Company, Danaher Corp, Others |
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Opportunities and Challenges in the Market
8 Global Point-of-Care (POC) Diagnostics Market Analysis
8.1 Key Industry Highlights
8.2 Global Point-of-Care (POC) Diagnostics Historical Market (2018-2023)
8.3 Global Point-of-Care (POC) Diagnostics Market Forecast (2024-2032)
8.4 Global Point-of-Care (POC) Diagnostics Market by Product
8.4.1 Glucose Monitoring Kits
8.4.1.1 Historical Trend (2018-2023)
8.4.1.2 Forecast Trend (2024-2032)
8.4.2 Infectious Diseases Testing Kits
8.4.2.1 Historical Trend (2018-2023)
8.4.2.2 Forecast Trend (2024-2032)
8.4.3 Pregnancy and Fertility Testing Kits
8.4.3.1 Historical Trend (2018-2023)
8.4.3.2 Forecast Trend (2024-2032)
8.4.4 Haematology Testing Kits
8.4.4.1 Historical Trend (2018-2023)
8.4.4.2 Forecast Trend (2024-2032)
8.4.5 Cardiometabolic Monitoring Kits
8.4.5.1 Historical Trend (2018-2023)
8.4.5.2 Forecast Trend (2024-2032)
8.4.6 Urinalysis Testing Devices
8.4.6.1 Historical Trend (2018-2023)
8.4.6.2 Forecast Trend (2024-2032)
8.4.7 Coagulation Monitoring Kits
8.4.7.1 Historical Trend (2018-2023)
8.4.7.2 Forecast Trend (2024-2032)
8.4.8 Tumour or Cancer Markers Testing Devices
8.4.8.1 Historical Trend (2018-2023)
8.4.8.2 Forecast Trend (2024-2032)
8.4.9 Cholesterol Testing Strips
8.4.9.1 Historical Trend (2018-2023)
8.4.9.2 Forecast Trend (2024-2032)
8.4.10 Drugs of Abuse Testing Kits
8.4.10.1 Historical Trend (2018-2023)
8.4.10.2 Forecast Trend (2024-2032)
8.4.11 Faecal Occult Testing Kits
8.4.11.1 Historical Trend (2018-2023)
8.4.11.2 Forecast Trend (2024-2032)
8.4.12 Others
8.5 Global Point-of-Care (POC) Diagnostics Market by Platform
8.5.1 Lateral Flow Assays
8.5.1.1 Historical Trend (2018-2023)
8.5.1.2 Forecast Trend (2024-2032)
8.5.2 Dipsticks
8.5.2.1 Historical Trend (2018-2023)
8.5.2.2 Forecast Trend (2024-2032)
8.5.3 Microfluidics
8.5.3.1 Historical Trend (2018-2023)
8.5.3.2 Forecast Trend (2024-2032)
8.5.4 Molecular Diagnostics
8.5.4.1 Historical Trend (2018-2023)
8.5.4.2 Forecast Trend (2024-2032)
8.5.5 Immunoassays
8.5.5.1 Historical Trend (2018-2023)
8.5.5.2 Forecast Trend (2024-2032)
8.5.6 Others
8.6 Global Point-of-Care (POC) Diagnostics Market by Mode of Purchase
8.6.1 Prescription-Based Products
8.6.1.1 Historical Trend (2018-2023)
8.6.1.2 Forecast Trend (2024-2032)
8.6.2 OTC Products
8.6.2.1 Historical Trend (2018-2023)
8.6.2.2 Forecast Trend (2024-2032)
8.7 Global Point-of-Care (POC) Diagnostics Market by End Use
8.7.1 Professional Diagnostic Centres
8.7.1.1 Historical Trend (2018-2023)
8.7.1.2 Forecast Trend (2024-2032)
8.7.2 Hospitals/Critical Care Centres
8.7.2.1 Historical Trend (2018-2023)
8.7.2.2 Forecast Trend (2024-2032)
8.7.3 Assisted Living Healthcare Facilities
8.7.3.1 Historical Trend (2018-2023)
8.7.3.2 Forecast Trend (2024-2032)
8.7.4 Research Laboratories
8.7.4.1 Historical Trend (2018-2023)
8.7.4.2 Forecast Trend (2024-2032)
8.8 Global Point-of-Care (POC) Diagnostics Market by Region
8.8.1 North America
8.8.1.1 Historical Trend (2018-2023)
8.8.1.2 Forecast Trend (2024-2032)
8.8.2 Europe
8.8.2.1 Historical Trend (2018-2023)
8.8.2.2 Forecast Trend (2024-2032)
8.8.3 Asia Pacific
8.8.3.1 Historical Trend (2018-2023)
8.8.3.2 Forecast Trend (2024-2032)
8.8.4 Latin America
8.8.4.1 Historical Trend (2018-2023)
8.8.4.2 Forecast Trend (2024-2032)
8.8.5 Middle East and Africa
8.8.5.1 Historical Trend (2018-2023)
8.8.5.2 Forecast Trend (2024-2032)
9 North America Point-of-Care (POC) Diagnostics Market Analysis
9.1 United States of America
9.1.1 Historical Trend (2018-2023)
9.1.2 Forecast Trend (2024-2032)
9.2 Canada
9.2.1 Historical Trend (2018-2023)
9.2.2 Forecast Trend (2024-2032)
10 Europe Point-of-Care (POC) Diagnostics Market Analysis
10.1 United Kingdom
10.1.1 Historical Trend (2018-2023)
10.1.2 Forecast Trend (2024-2032)
10.2 Germany
10.2.1 Historical Trend (2018-2023)
10.2.2 Forecast Trend (2024-2032)
10.3 France
10.3.1 Historical Trend (2018-2023)
10.3.2 Forecast Trend (2024-2032)
10.4 Italy
10.4.1 Historical Trend (2018-2023)
10.4.2 Forecast Trend (2024-2032)
10.5 Others
11 Asia Pacific Point-of-Care (POC) Diagnostics Market Analysis
11.1 China
11.1.1 Historical Trend (2018-2023)
11.1.2 Forecast Trend (2024-2032)
11.2 Japan
11.2.1 Historical Trend (2018-2023)
11.2.2 Forecast Trend (2024-2032)
11.3 India
11.3.1 Historical Trend (2018-2023)
11.3.2 Forecast Trend (2024-2032)
11.4 ASEAN
11.4.1 Historical Trend (2018-2023)
11.4.2 Forecast Trend (2024-2032)
11.5 Australia
11.5.1 Historical Trend (2018-2023)
11.5.2 Forecast Trend (2024-2032)
11.6 Others
12 Latin America Point-of-Care (POC) Diagnostics Market Analysis
12.1 Brazil
12.1.1 Historical Trend (2018-2023)
12.1.2 Forecast Trend (2024-2032)
12.2 Argentina
12.2.1 Historical Trend (2018-2023)
12.2.2 Forecast Trend (2024-2032)
12.3 Mexico
12.3.1 Historical Trend (2018-2023)
12.3.2 Forecast Trend (2024-2032)
12.4 Others
13 Middle East and Africa Point-of-Care (POC) Diagnostics Market Analysis
13.1 Saudi Arabia
13.1.1 Historical Trend (2018-2023)
13.1.2 Forecast Trend (2024-2032)
13.2 United Arab Emirates
13.2.1 Historical Trend (2018-2023)
13.2.2 Forecast Trend (2024-2032)
13.3 Nigeria
13.3.1 Historical Trend (2018-2023)
13.3.2 Forecast Trend (2024-2032)
13.4 South Africa
13.4.1 Historical Trend (2018-2023)
13.4.2 Forecast Trend (2024-2032)
13.5 Others
14 Market Dynamics
14.1 SWOT Analysis
14.1.1 Strengths
14.1.2 Weaknesses
14.1.3 Opportunities
14.1.4 Threats
14.2 Porter’s Five Forces Analysis
14.2.1 Supplier’s Power
14.2.2 Buyer’s Power
14.2.3 Threat of New Entrants
14.2.4 Degree of Rivalry
14.2.5 Threat of Substitutes
14.3 Key Indicators for Demand
14.4 Key Indicators for Price
15 Competitive Landscape
15.1 Market Structure
15.2 Company Profiles
15.2.1 Abbott Point of Care Inc.
15.2.1.1 Company Overview
15.2.1.2 Product Portfolio
15.2.1.3 Demographic Reach and Achievements
15.2.1.4 Certifications
15.2.2 F. Hoffmann-La Roche Ltd
15.2.2.1 Company Overview
15.2.2.2 Product Portfolio
15.2.2.3 Demographic Reach and Achievements
15.2.2.4 Certifications
15.2.3 Chembio Diagnostics, Inc.
15.2.3.1 Company Overview
15.2.3.2 Product Portfolio
15.2.3.3 Demographic Reach and Achievements
15.2.3.4 Certifications
15.2.4 Johnson & Johnson Services, Inc.
15.2.4.1 Company Overview
15.2.4.2 Product Portfolio
15.2.4.3 Demographic Reach and Achievements
15.2.4.4 Certifications
15.2.5 Siemens AG
15.2.5.1 Company Overview
15.2.5.2 Product Portfolio
15.2.5.3 Demographic Reach and Achievements
15.2.5.4 Certifications
15.2.6 Becton, Dickinson and Company
15.2.6.1 Company Overview
15.2.6.2 Product Portfolio
15.2.6.3 Demographic Reach and Achievements
15.2.6.4 Certifications
15.2.7 Danaher Corp
15.2.7.1 Company Overview
15.2.7.2 Product Portfolio
15.2.7.3 Demographic Reach and Achievements
15.2.7.4 Certifications
15.2.8 Others
16 Key Trends and Developments in the Market
List of Key Figures and Tables
1. Global Point-of-Care (POC) Diagnostics Market: Key Industry Highlights, 2018 and 2032
2. Global Point-of-Care (POC) Diagnostics Historical Market: Breakup by Product (USD Billion), 2018-2023
3. Global Point-of-Care (POC) Diagnostics Market Forecast: Breakup by Product (USD Billion), 2024-2032
4. Global Point-of-Care (POC) Diagnostics Historical Market: Breakup by Platform (USD Billion), 2018-2023
5. Global Point-of-Care (POC) Diagnostics Market Forecast: Breakup by Platform (USD Billion), 2024-2032
6. Global Point-of-Care (POC) Diagnostics Historical Market: Breakup by Mode of Purchase (USD Billion), 2018-2023
7. Global Point-of-Care (POC) Diagnostics Market Forecast: Breakup by Mode of Purchase (USD Billion), 2024-2032
8. Global Point-of-Care (POC) Diagnostics Historical Market: Breakup by End Use (USD Billion), 2018-2023
9. Global Point-of-Care (POC) Diagnostics Market Forecast: Breakup by End Use (USD Billion), 2024-2032
10. Global Point-of-Care (POC) Diagnostics Historical Market: Breakup by Region (USD Billion), 2018-2023
11. Global Point-of-Care (POC) Diagnostics Market Forecast: Breakup by Region (USD Billion), 2024-2032
12. North America Point-of-Care (POC) Diagnostics Historical Market: Breakup by Country (USD Billion), 2018-2023
13. North America Point-of-Care (POC) Diagnostics Market Forecast: Breakup by Country (USD Billion), 2024-2032
14. Europe Point-of-Care (POC) Diagnostics Historical Market: Breakup by Country (USD Billion), 2018-2023
15. Europe Point-of-Care (POC) Diagnostics Market Forecast: Breakup by Country (USD Billion), 2024-2032
16. Asia Pacific Point-of-Care (POC) Diagnostics Historical Market: Breakup by Country (USD Billion), 2018-2023
17. Asia Pacific Point-of-Care (POC) Diagnostics Market Forecast: Breakup by Country (USD Billion), 2024-2032
18. Latin America Point-of-Care (POC) Diagnostics Historical Market: Breakup by Country (USD Billion), 2018-2023
19. Latin America Point-of-Care (POC) Diagnostics Market Forecast: Breakup by Country (USD Billion), 2024-2032
20. Middle East and Africa Point-of-Care (POC) Diagnostics Historical Market: Breakup by Country (USD Billion), 2018-2023
21. Middle East and Africa Point-of-Care (POC) Diagnostics Market Forecast: Breakup by Country (USD Billion), 2024-2032
22. Global Point-of-Care (POC) Diagnostics Market Structure
Key Questions Answered in the Report
The market is projected to grow at a CAGR of 8% between 2024 and 2032.
The major drivers of the market include the rising geriatric population and the rising prevalence of acute and chronic diseases.
The point-of-care (POC) diagnostic market is being aided by rapidly increasing acute and chronic diseases.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
Glucose monitoring kits, infectious diseases testing kits, pregnancy and fertility testing kits, haematology testing kits, cardiometabolic monitoring kits, urinalysis testing devices, coagulation monitoring kits, tumour or cancer markers testing devices, cholesterol testing strips, drugs of abuse testing kits, and faecal occult testing kits, among others are the leading products in the industry.
Lateral flow assays, dipsticks, microfluidics, molecular diagnostics, and immunoassays, among others are the leading platforms in the industry.
Prescription-based products and OTC products are the leading mode of purchase in the industry.
Professional diagnostic centres, hospitals/critical care centres, assisted living healthcare facilities, and research laboratories are the leading end-uses in the industry.
The major players in the industry are Abbott Point of Care Inc., F. Hoffmann-La Roche Ltd, Chembio Diagnostics, Inc., Johnson & Johnson Services, Inc., Siemens AG, Becton, Dickinson and Company, and Danaher Corp, among others.
Analyst Review
The global point-of-care (POC) diagnostic market is driven by the rising geriatric population and the rising prevalence of acute and chronic diseases. The market is expected to witness further growth in the forecast period of 2024-2032, growing at a CAGR of 8%.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on its products, the point-of-care (POC) diagnostic industry can be segmented into glucose monitoring kits, infectious diseases testing kits, pregnancy and fertility testing kits, haematology testing kits, cardiometabolic monitoring kits, urinalysis testing devices, coagulation monitoring kits, tumour or cancer markers testing devices, cholesterol testing strips, drugs of abuse testing kits, and faecal occult testing kits, among others. On the basis of platforms, the market is divided into lateral flow assays, dipsticks, microfluidics, molecular diagnostics, and immunoassays, among others. On the basis of mode of purchase, the market is divided into prescription-based products and OTC products. On the basis of end uses, the market is segmented into professional diagnostic centres, hospitals/critical care centres, assisted living healthcare facilities, and research laboratories. The major regional markets for point-of-care (POC) diagnostic are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Abbott Point of Care Inc., F. Hoffmann-La Roche Ltd, Chembio Diagnostics, Inc., Johnson & Johnson Services, Inc., Siemens AG, Becton, Dickinson and Company, and Danaher Corp, among others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$1699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$2799
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$3999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$4999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER